Resident CD49a + CD103 + NKG2C + NK cells restrict HIV infection in human lymphoid tissue explants
Science Advances · 23.01.2026 · 12 (4)
DOI: 10.1126/sciadv.adz1565 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Advances, erschienen am 23.01.2026. Verfasst von David Perea und 10 weiteren Autor:innen. Beteiligte Einrichtung: HIV Translational Laboratory, Infectious Diseases Department, Vall d'Hebron Research Institute (VHIR), Autonomous University of Barcelona, 08035 Barc…. Hauptthemen laut MEDLINE: Killer Cells, Natural, HIV Infections, Antigens, CD, Integrin alpha Chains. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 88 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Gilead Sciences, Instituto de Salud Carlos III, Agencia Estatal de Investigación.
Abstract (Originalsprache)
Natural killer (NK) cells are pivotal effectors in antiviral immunity, yet their tissue-specific roles during acute HIV infection remain poorly defined. Using an ex vivo human tonsillar tissue model, we profile NK cell responses to early HIV infection and uncover distinct subsets with specialized functions. We identify a previously uncharacterized memory-like NK population (CD16 +/− CD69 + CD49a + CD103 + NKG2C + ) associated with reduced viral burden and enriched in cytotoxic mediators (GNLY, PRF1, and GZMB), apoptotic ligands (FASLG and TRAIL), cytokine receptors (IL2RA, IL2RB, IL2RG, IL12RB2, and IL18R1) and trafficking molecules (CCL3–5, CCR7, and SELL). Although functionally capable of clearing HIV-infected CD4 + T cells in a tissue-mimetic environment, they show impaired cytotoxicity and transcriptional signs of exhaustion after infection. Conversely, HIV drives the reprogramming of immature CD16 − CD69 + NK cells toward a more cytotoxic and migratory effector phenotype. These findings reveal dynamic NK cell adaptations in lymphoid tissue during early HIV infection and highlight tissue-resident NK cells as promising targets for immunotherapeutic intervention.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- HIV Translational Laboratory, Infectious Diseases Department, Vall d'Hebron Research Institute (VHIR), Autonomous University of Barcelona, 08035 Barcelona, Spain.
- Department of Otorhinolaryngology, Vall d'Hebron University Hospital, 08035 Barcelona, Spain.
- Infectious Diseases Department, Vall d'Hebron University Hospital, 08035 Barcelona, Spain.
ORCID-Profile: David Perea, Alba Gonzalez, Ana Gallego-Cortés, Nerea Sanchez-Gaona, Felix Pumarola, Nuria Ortiz, Juan Lorente, Vicenç Falcó, Meritxell Genescà, Maria J Buzon
Förderung
- Gilead Sciences
- Instituto de Salud Carlos III
- Agencia Estatal de Investigación
- “la Caixa” Banking Foundation
- Vall d´Hebron Research Institute
Zitieren
APA
Perea, D., Gonzalez, A., Gallego-Cortés, A., Sanchez-Gaona, N., Pumarola, F., Ortiz, N., Llano, I., Lorente, J., Falcó, V., Genescà, M., & Buzon, M. J. (2026). Resident CD49a + CD103 + NKG2C + NK cells restrict HIV infection in human lymphoid tissue explants. Science Advances, 12(4). https://doi.org/10.1126/sciadv.adz1565
Vancouver
Perea D, Gonzalez A, Gallego-Cortés A, Sanchez-Gaona N, Pumarola F, Ortiz N, et al. Resident CD49a + CD103 + NKG2C + NK cells restrict HIV infection in human lymphoid tissue explants. Science Advances. 2026;12(4). doi:10.1126/sciadv.adz1565
BibTeX
@article{Perea2026,
author = {Perea, David and Gonzalez, Alba and Gallego-Cortés, Ana and Sanchez-Gaona, Nerea and Pumarola, Felix and Ortiz, Nuria and Llano, Ines and Lorente, Juan and Falcó, Vicenç and Genescà, Meritxell and Buzon, Maria J},
title = {Resident CD49a + CD103 + NKG2C + NK cells restrict HIV infection in human lymphoid tissue explants},
journal = {Science Advances},
year = {2026},
volume = {12},
number = {4},
doi = {10.1126/sciadv.adz1565}
}
EUVIMED